CMT2E Foundation

We are a non-profit dedicated to accelerating the discovery of treatments for Charcot-Marie-Tooth disease Type 2E (CMT2E). CMT2E is a progressive neurodegenerative disorder that impacts 1 in 250,000 people. Our foundation acts as a connector — bridging collaborations between world-class innovators, clinical experts, and patient families.